Regeneron Pharmaceuticals
REGN
#117
Rank
HK$990.82 B
Marketcap
HK$8,988
Share price
-0.02%
Change (1 day)
39.45%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): HK$292.56

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$291.22. In 2022 the company made an earnings per share (EPS) of HK$315.86 a decrease over its 2021 EPS that were of HK$595.93.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$292.56-7.38%
2022HK$315.86-47%
2021HK$595.93133.36%
2020HK$255.3769.13%
2019HK$150.99-14.44%
2018HK$176.48100.71%
2017HK$87.9331.78%
2016HK$66.7338.96%
2015HK$48.0272.55%
2014HK$27.83-17.55%
2013HK$33.75-44.98%
2012HK$61.35-422.54%
2011-HK$19.0292.13%
2010-HK$9.9049.41%
2009-HK$6.63-15.84%
2008-HK$7.87-36.88%
2007-HK$12.47-9.6%
2006-HK$13.804.12%
2005-HK$13.25-323.68%
2004HK$5.92-135.51%
2003-HK$16.68-24.38%
2002-HK$22.0656.35%
2001-HK$14.11187.3%
2000-HK$4.91-16%
1999-HK$5.85177.78%
1998-HK$2.10-35.71%
1997-HK$3.27-68.42%
1996-HK$10.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$110.30-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$32.04-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$143.90-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$109.80-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$29.15-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$24.79-91.49%๐Ÿ‡ซ๐Ÿ‡ท France